Risk Factors for <i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study
Background: Very few cases of <i>Pneumocystis jirovecii</i> pneumonia (PJP) have been reported in COVID-19 so far, and mostly in patients with concomitant HIV infection or in solid-organ transplant recipients. Despite COVID-19 being associated with lymphopenia and the use of steroids, th...
Main Authors: | Giulio Viceconte, Antonio Riccardo Buonomo, Alessia D’Agostino, Maria Foggia, Antonio Di Fusco, Biagio Pinchera, Riccardo Scotto, Carmine Iacovazzo, Luca Fanasca, Gaetana Messina, Francesco Cacciatore, Paola Salvatore, Ivan Gentile, on behalf of the Federico II COVID Team |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/9/8/838 |
Similar Items
-
Prevalence of <i>Pneumocystis jirovecii</i> Colonization in Non-Critical Immunocompetent COVID-19 Patients: A Single-Center Prospective Study (JiroCOVID Study)
by: Antonio Riccardo Buonomo, et al.
Published: (2023-11-01) -
Molecular diagnosis of Pneumocystis jirovecii pneumonia by using External PCR in immunocompromised patients .
by: Arkan A. Al-Qaisi, et al.
Published: (2014-04-01) -
<i>Pneumocystis jirovecii</i> Pneumonia in Children with Hematological Malignancies: Diagnosis and Approaches to Management
by: Elpis Mantadakis
Published: (2020-12-01) -
Determining <i>Pneumocystis jirovecii</i> Colonisation from Infection Using PCR-Based Diagnostics in HIV-Negative Individuals
by: Anna Louise Watson, et al.
Published: (2024-01-01) -
Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway
by: Stine Grønseth, et al.
Published: (2021-07-01)